NIH Clinical Center: Search the Studies

Search the Studies

12 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
000954-C	A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients with Advanced Mesothelin-Expressing Cancer	No longer recruiting/follow-up only	18-120 Years	NCI	Cholangiocarcinoma
000473-C	A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR-Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma	Participants currently recruited/enrolled	18-125 Years	NCI	Cholangiocarcinoma
000307-C	Phase II Study Evaluating the Efficacy of M9241 in Combination with Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects with Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma	Participants currently recruited/enrolled	18-125 Years	NCI	Cholangiocarcinoma
000237-C	Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis from Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer	Participants currently recruited/enrolled	18-125 Years	NCI	Cholangiocarcinoma
21-C-0006	Phase II Study Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers	Participants currently recruited/enrolled	18-125 Years	NCI	Cholangiocarcinoma
20-C-0006	A National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer (PLC)	Participants currently recruited/enrolled	18-125 Years	NCI	Cholangiocarcinoma
19-C-0128	A Phase I Study of Mesothelin-Targeted Immunotoxin LMB-100 in Combination with Tofacitinib in Persons with Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and other Mesothelin Expressing Solid Tumors	Completed Study; data analyses ongoing	18-125 Years	NCI	Cholangiocarcinoma
19-C-0117	A Phase 1 / 2 Single Arm Open-label Clinical Trial of Gavocabtagene Autoleucel (gavo-cel) in Patients with Advanced Mesothelin Expressing Cancer	No longer recruiting/follow-up only	18-120 Years	NCI	Cholangiocarcinoma
19-C-0039	Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers	Completed Study; data analyses ongoing	18-125 Years	NCI	Cholangiocarcinoma
16-C-0135	A Pilot Study of Combined Immune Checkpoint Inhibition in combination with Ablative Therapies in Subjects with Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)	Completed Study; data analyses ongoing	18-125 Years	NCI	Cholangiocarcinoma
16-C-0128	A Phase I/II Study of Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination with Nab-Paclitaxel in Participants with Previously Treated Metastatic and/ or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors	Completed Study; data analyses ongoing	18-125 Years	NCI	Cholangiocarcinoma
13-C-0176	Tumor, Normal Tissue and Specimens from Patients Undergoing Evaluation or Surgical Resection of Solid Tumors	Participants currently recruited/enrolled	2-125 Years	NCI	Cholangiocarcinoma